LENSAR (LNSR) Projected to Post Earnings on Thursday

LENSAR (NASDAQ:LNSR) is anticipated to issue its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect LENSAR to post earnings of ($0.10) per share and revenue of $20.30 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, March 6, 2026 at 8:30 AM ET.

LENSAR Stock Performance

Shares of LNSR stock opened at $11.95 on Wednesday. The stock has a fifty day moving average price of $12.00 and a 200 day moving average price of $11.84. The stock has a market cap of $142.68 million, a PE ratio of -2.72 and a beta of 0.69. LENSAR has a 1 year low of $9.13 and a 1 year high of $17.31.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on LNSR shares. Wall Street Zen upgraded shares of LENSAR to a “hold” rating in a research report on Friday, November 28th. Weiss Ratings restated a “sell (d-)” rating on shares of LENSAR in a research report on Thursday, January 22nd. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and a consensus price target of $15.00.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its stake in shares of LENSAR by 212.4% during the 4th quarter. Royal Bank of Canada now owns 11,277 shares of the company’s stock worth $131,000 after purchasing an additional 7,667 shares during the last quarter. Barclays PLC raised its position in shares of LENSAR by 10.3% in the fourth quarter. Barclays PLC now owns 14,857 shares of the company’s stock valued at $173,000 after buying an additional 1,389 shares during the last quarter. State Street Corp lifted its stake in shares of LENSAR by 4.6% during the fourth quarter. State Street Corp now owns 123,720 shares of the company’s stock valued at $1,439,000 after buying an additional 5,470 shares during the period. Dynamic Technology Lab Private Ltd boosted its position in LENSAR by 436.6% during the fourth quarter. Dynamic Technology Lab Private Ltd now owns 54,166 shares of the company’s stock worth $630,000 after acquiring an additional 44,072 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its position in LENSAR by 69.4% during the fourth quarter. Wells Fargo & Company MN now owns 10,734 shares of the company’s stock worth $125,000 after acquiring an additional 4,398 shares during the last quarter. Institutional investors and hedge funds own 40.15% of the company’s stock.

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.